riluzole has been researched along with Carcinoma, Anaplastic in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z | 1 |
| Qiao, X | 2 |
| Liu, XM | 1 |
| Shi, SH | 1 |
| Xu, JY | 1 |
1 other study available for riluzole and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Blocking xCT and PI3K/Akt pathway synergized with DNA damage of Riluzole-Pt(IV) prodrugs for cancer treatment.
Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; DNA Damage; Humans; Phosphatidylinosi | 2023 |